MISC

A new University at Buffalo study conducted at John R. Oishei Children's Hospital is one of the first to reveal that there were fewer cases of multi-system inflammatory syndrome in children (MIS-C) during the omicron wave of the pandemic…

A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence. About half of…

New research findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but potentially life-threatening disease. The…

Scientists at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C), they report in Clinical Care…

A young child in Wisconsin under the age of ten years old has died of Covid-related Multisystem Inflammatory Syndrome in Children (MIS-C), the first of this sort of death in America.The condition is tied to 'long Covid', the mysterious…

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection. The syndrome is rare, and it remains unclear how the viral infection leads to MIS-C and why it only develops in some…

A rare but serious inflammatory condition that affects children who contract COVID-19 produces a distinctive pattern of biomarkers that may help physicians predict disease severity and also aid researchers in developing new treatments,…